Journal of diabetes science and technology
Use of the Glycemia Risk Index at Hybrid Closed-Loop Initiation to Predict Combined International Glucose Targets at 12 Months: Results From the CIRDIA Study Group.
Sylvie Picard, Joëlle Dupont, Fabienne Amiot-Chapoutot, Blandine Courbebaisse, Estelle Personeni, Emmanuelle Lecornet-Sokol, François Mougel, Clara Bouché, Françoise Giroud, Sandrine Lablanche, Sophie Borot
Published: 202510.1177/19322968251380291
Abstract
BACKGROUND: Hybrid closed-loop (HCL) therapy helps reaching efficacy and safety glucose targets (ESGT+) in persons with type 1 diabetes (PwT1D). We analyzed here the glycemia risk index (GRI) in PwT1D at HCL initiation (M0) and at 12 months (M12) and…
Preview only. Read the full abstract at the source